David B. Trollinger

David B. Trollinger has a diverse work experience in the healthcare and biotechnology industries. David B. started their career as an Associate Scientist at Amgen, where they managed DNA sequencing and RNA expression analysis lab operations. David B. then joined Source Precision Medicine (Source MDx) as Vice President, Molecular Technologies, where they co-founded a personalized medicine company and developed commercial assays. David later worked at Array BioPharma as a Translational Medicine Manager and at Nextgen Pharma Technologies as the Clinical and Translational Research Division Director. David B. also served as the R&D Program Manager at Amicrobe, an advanced biomaterials company focused on infection prevention in hospitals. Currently, they are the Director of Business Development at National Jewish Health, a leading respiratory, medical, and research institution that collaborates with pharmaceutical and biotechnology companies to improve patient care.

David B. Trollinger holds a Master of Business Administration (MBA) from the University of Colorado. David B. also completed a Bachelor of Science (B.Sc.) in Biology at the University of California, Riverside. Additionally, they attended Villa Park High School.